Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1707 of 6351
-
Can training the mind boost a Nurse's inner strength?
Symptom relief CompletedThe nursing profession, comprising over 27.9 million individuals and representing 59% of the health sector, plays a critical role in frontline healthcare globally. However, nurses face significant workplace stress due to factors like high mortality rates and ethical dilemmas, whi…
Sponsor: Fitria Endah Janitra • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New drug trial aims to tame hardening skin and lung damage in scleroderma
Disease control Recruiting nowThe purpose of this study is to evaluate efficacy, safety and tolerability of s.c. ianalumab administered in participants with diffuse cutaneous systemic sclerosis relative to placebo
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 06:00 UTC
-
Blood test may spot head and neck Cancer's return
Knowledge-focused Recruiting nowThis is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radia…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Zapping the brain to fight forgetfulness: new dementia trial launches
Symptom relief Recruiting nowThis research investigates the effect of different frequencies of tACS (0 Hz, 30 Hz, 50 Hz, 70 Hz, 90 Hz) and tRNS with cognitive exercises in a regimen protocol of 4 weeks, everyday (Monday to Friday). The study design is a longitudinal study design in which participants receive…
Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Shocking the vagus nerve: new hope for stroke recovery?
Disease control Recruiting nowVagal Nerve Stimulation is a novel proven therapy for patients with chronic ischemic stroke. The primary objective of this registry is to assess the safety of vagal nerve stimulation for stroke recovery through monitoring the occurrence of serious adverse events associated with t…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immune cells trained to fight ovarian cancer in new trial
Disease control Recruiting nowThe goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy in recurrent, high grade ovarian cancer (HGOC). Names of the study therapies involved in this study are: CIML NK (cellu…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for diabetes-related vision loss: experimental drug faces final test
Disease control Recruiting nowA multicenter, randomized, double-blind, parallel-group, active-controlled non-inferiority trial. A total of 406 subjects with diabetic macular edema (DME) were planned for enrollment. After screening, eligible subjects were randomized in a 1:1 ratio to the treatment group or the…
Phase 3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo aims to stall lung Cancer's spread
Disease control Recruiting nowThis phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy (SBRT) with osimertinib works for the treatment of EGFR positive non-small cell lung carcinoma that has spread from where it first started (primary site) to a l…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Midwife-Led birth units may boost Parents' mental health years after childbirth
Knowledge-focused CompletedMajority of pregnancies and childbirths in France occur without complication. While the impact of care failure on maternal and neonatal morbi-mortality is now well- established, the literature reveals that an overmedicalization of pregnancy and childbirth care is not associated w…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to predict which prostate cancer patients benefit from Lu-PSMA therapy
Knowledge-focused Recruiting nowProstate cancer is the most common cancer in men. Its incidence is rising as the population ages. In the localized stage, the 5-year overall survival rate (OS) is 98%. Metastatic progression and resistance to castration have a negative impact on prognosis. Despite recent advances…
Sponsor: Centre Jean Perrin • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids with rare muscle disease: rozanolixizumab safety trial expands
Disease control By invitation onlyThe purpose of the study is to assess the long term safety and tolerability of additional 6-week treatment cycles with rozanolixizumab in pediatric participants with generalized Myasthenia Gravis (gMG) aged ≥2 at the time of the Screening Visit of MG0006.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Parents as therapists: new autism trial tests Home-Based training
Symptom relief By invitation onlyPurpose of the Research: The goal of this clinical study is to investigate if a parent training program called "Project IMPACT" (Improving Parents as Communication Teachers) can help improve the core challenges in social interaction and communication for children with Autism Spe…
Sponsor: University of Electronic Science and Technology of China • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New hope for advanced cancers: experimental drug ACR-2316 enters first human trial
Disease control Recruiting nowThis is a first in-human, Open-label Phase 1 study to assess the safety of ACR-2316 for the treatment of subjects with specific, histologically confirmed, locally advanced, recurrent or metastatic solid tumors.
Phase 1 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a home gluten test help heal celiac disease?
Disease control Recruiting nowThe investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention wil…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New program aims to ease depression and trauma in moms experiencing abuse
Symptom relief CompletedThe purpose of this R34 exploratory research proposal is to conduct formative work for a larger randomized controlled trial (RCT) evaluating the effectiveness of the "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent …
Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New diabetes combo aims to lower blood sugar in phase 3 trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental virus therapy takes on deadly brain cancer
Disease control Recruiting nowThis is a Phase 1/2a, open-label study to evaluate the safety, tolerability, immunogenicity, and preliminary clinical activity of RZ-001 administered in combination with VGCV in subjects with hTERT-positive GBM.
Phase 1/2 • Sponsor: Rznomics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:50 UTC
-
New diabetes drug shows promise in Mid-Stage trial
Disease control CompletedThis is a Phase IIb, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes mellitus, compared to placebo and active comparator.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Single dose of esketamine during surgery may ward off Post-Op depression in ovarian cancer patients
Prevention CompletedThe goal of this clinical trial is to learn if intraoperative administration of esketamine would prevent or mitigate postoperative depressive symptoms after cytoreductive surgery in ovarian cancer. The main questions it aims to answer are: * Whether a single low dose of esketami…
Sponsor: Zhejiang Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New allergy vaccine could end spring sniffles
Symptom relief OngoingThis is first-in-human phase 1/2 clinical trial to evaluate the safety, systemic and local reactogenicity of GNR-127 at the first stage in sequential cohorts of patients with allergic rhinitis with sensitization to the birch pollen, and then to determine and evaluate an effective…
Phase 1/2 • Sponsor: AO GENERIUM • Aim: Symptom relief
Last updated Jun 26, 2026 13:40 UTC